Smart Inhaler Technology  Market Anticipated  to grow at CAGR 25.1%, Business Overview 2023, and Forecast to 2030

The Smart Inhaler Technology market reports provide a detailed analysis of area market expansion, competitiveness, global and regional market size and growth analysis. It also offers recent developments such as market share, opportunity analysis, product launch and sales analysis, segmentation growth, market innovation and value chain optimization and SWOT analysis. The latest reports on the market cover the current impact of COVID-19 on the market. This has brought about some changes in market conditions. Early and future assessments of rapidly changing Smart Inhaler Technology market scenarios and impacts are covered in the report.

Market Overview:

A smart inhaler is a medical device that uses a person’s breathing to deliver medicines into their lungs. This allows medicines to be delivered to and absorbed in the lungs, allowing for more targeted medical treatment in this area of the body and a reduction in the side effects of oral medications. Inhalers come in a variety of shapes and sizes, and they’re commonly used to treat a variety of medical conditions, the most common of which are asthma and chronic obstructive pulmonary disease (COPD). Metered-dose inhalers, dry powder inhalers, soft mist inhalers, and nebulizers are some of the most common types of inhalers. Each device has benefits and drawbacks and can be chosen based on the needs of the individual patient, as well as their age, pathological conditions, coordination, and lung function. For the inhaled medication to have the desired effects on the lungs, proper inhaler training is required.

Smart inhalers are devices intended to connect to the mobile application via Bluetooth to properly manage chronic respiratory disorders and improve the lifestyle of patients. The increase in demand for smart inhalers has been amplified exponentially due to the increasing prevalence of respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disorders, among others. Smart inhalers are an upgrade to conventional inhalers. They include the use of link technology and usage sensors through which the overall system collects and stores information about the patient’s habits and needs. This connectivity technology helps inform patients when to refill inhalers and when to take medication, even increasing the amount based on the patient’s condition.

Contrive Datum Insights analyses that the global Smart Inhaler Technology market to be growing at a CAGR of 25.1% in the forecast period of 2023-2030.

Get Full PDF Sample Copy of Report:

Top Companies in the Global Smart Inhaler Technology Market:

3M, Abbott Laboratories, Propeller Health, Teva Pharmaceuticals, Adherium, Cohero Health, and others.

Recent Development:

In February 2020, Teva Respiratory, LLC, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that the ArmonAir Digihaler (Inhalation Powder) has been approved by the US Food and Drug Administration. It is administered using Teva’s Digihaler device. It is approved for the treatment of asthma in patients aged 12 and up.

In April 2020, AptarGroup, Inc. and Sonmol, a Chinese digital respiratory therapeutics company, collaborated to create a digital therapies and services platform for respiratory and other diseases. This collaboration will help to focus on early detection and prevention measures for chronic respiratory diseases, which will strengthen the case for smart inhalers and connected devices as platforms for improving patient health.

In August 2020, Propeller Health collaborated with Novartis to connect the digital health platform to the medications Enerzair and Atectura Breezhaler, which will be distributed in Japan to treat uncontrolled asthma. The company’s digital health sensor will assist people in Japan in managing their health conditions via the Propeller app on their smartphones.

This report segments the global market based on Types are:



This report segments the global market based on Applications are:



By Distribution channels:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Regional Outlook: Regions covered in the market report is:

North America dominates the smart inhalers market due to growing per capita income, rising prevalence Of COPD and asthma, growth in population susceptible to indoor air pollutants, increase in air pollution, rising collaboration between pharma and digital health companies and rising prevalence of respiratory diseases in this region.

Asia-Pacific is the expected region in terms of development in smart inhalers market due to rising need to rising healthcare expenditure and an cumulative number of product growth in this region.

North America (U.S., Canada)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

South America (Mexico, Brazil, Argentina, Columbia, Rest of South America)

Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Year Considered Estimating the Market Size:

  • Historical Years: 2017-2022
  • Base Year: 2023
  • Forecast Period: 2023-2030

 Significance of the report which makes it worth buying:

– A broad and precise understanding of Smart Inhaler Technology Industry is offered in the segmented form based on product types, applications, and regions.

– Smart Inhaler Technology Industry Drivers and challenges affecting the industry growth are presented in this report.

– Evaluating the market competition and planning the business strategies accordingly

– Understanding Smart Inhaler Technology Industry business plans, policies, technological advancements, and company profiles of top players.

Table of Contents:

Part 01: Executive Summary

Part 02: Scope of the Smart Inhaler Technology Market Report

Part 03: Global Market Landscape

Part 04: Global Smart Inhaler Technology Market Sizing

Part 05: Global Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Buy This Research Report Now –

Some of the key questions answered in this report:

Which are the key factors driving the Smart Inhaler Technology market?

What was and what will be the size of the emerging market in 2030?

Which region is expected to hold the highest market share in the market?

What trends, challenges, and barriers will impact the development and sizing of the global market?

What is the sales volume, revenue, and price analysis of top manufacturers of the market?

About Us:

Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials in various sectors including investment, information technology, telecommunications, consumer technology, and manufacturing markets. CDI helps investment communities, business executives and IT professionals make accurate, statistically-based decisions on technology purchases and promote strong growth tactics to maintain market competitiveness. Composed of a team of more than 100 analysts and a cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and national experience.

Contact Us:

Anna B. (Head Of sales) | Contrive Datum Insights
Contact No- IND: +91 9834816757 / CANADA: +1 2152974078



Leave a Reply

Your email address will not be published. Required fields are marked *